Latest filing published 02 Jul 2009 for REMEC INC, €1.9M.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Kellogg Capital Group LLC across 7 companies, led by Tidel Technologies Inc, Drugmax Inc and Armstrong Holdings Inc /PA/. Over a trading history stretching from 30 January 2006 to 1 July 2009, the count stands at 14 filings.
Market trades split into 3 purchases (€837k) and 11 sales (€5.3M). Netting one side against the other leaves €4.5M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2009 to date brings no purchases and 2 sales.
In size, the median ticket on the buying side is €29k.
The latest filing, published on 2 July 2009, reports an open-market sale of €1.9M in Remec Inc. The most recent open-market purchase was published on 21 February 2007, 7,185 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations